Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study. 2021

Masaaki Kodama, and Tadayoshi Okimoto, and Kazuhiro Mizukami, and Yuka Hirashita, and Yasuhiro Wada, and Masahide Fukuda, and Osamu Matsunari, and Kazuhisa Okamoto, and Ryo Ogawa, and Kensuke Fukuda, and Yoko Kudo, and Yoshinari Kawahara, and Kazunari Murakami
Department of Gastroenterology, Faculty of Medicine, Oita University, Yufu, Japan.

OBJECTIVE Improvement of atrophic gastritis and intestinal metaplasia (IM) is considered to reduce the gastric cancer risk, but whether it can be achieved by H. pylori eradication (HPE) remains controversial. To evaluate the effect of HPE, we observed the gastric mucosa for up to17 years after HPE and sex differences in gastric mucosa. METHODS In total, 172 patients (94 males, 78 females) with HPE were enrolled. Annual histological evaluations were performed for up to 17 years. The grades of mononuclear cells, neutrophils, atrophy, IM in the antrum and corpus were evaluated using the updated Sydney system. RESULTS Relative to the pre-HPE period, atrophy had improved significantly 1 year after HPE in the antrum (1.50 ± 0.75 vs. 1.21 ± 1.25, P < 0.01) and corpus (0.59 ± 0.75 vs. 0.18 ± 0.52, P < 0.05). IM showed no significant change during 17 years after HPE at either biopsy site. Atrophy scores did not differ significantly between males and females. IM scores were significantly higher in males than in females before eradication (antrum, 0.67 ± 0.94 vs. 0.44 ± 0.77, P = 0.003, corpus, 0.20 ± 0.62 vs. 0.047 ± 0.21, P = 0.0027) and at most observation timepoints. CONCLUSIONS During 17 years after HPE, atrophy, but not IM, improved significantly at the greater curvatures of the antrum and corpus. IM was significantly more severe in males than in females. Careful follow-up after HPE based on sex differences in gastric mucosal characteristics is important.

UI MeSH Term Description Entries
D008297 Male Males
D008679 Metaplasia A condition in which there is a change of one adult cell type to another similar adult cell type.
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009853 Omeprazole A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. H 168-68,Omeprazole Magnesium,Omeprazole Sodium,Prilosec,H 168 68,H 16868,Magnesium, Omeprazole,Sodium, Omeprazole
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D005757 Gastritis, Atrophic GASTRITIS with atrophy of the GASTRIC MUCOSA, the GASTRIC PARIETAL CELLS, and the mucosal glands leading to ACHLORHYDRIA. Atrophic gastritis usually progresses from chronic gastritis. Atrophic Gastritides,Atrophic Gastritis,Gastritides, Atrophic

Related Publications

Masaaki Kodama, and Tadayoshi Okimoto, and Kazuhiro Mizukami, and Yuka Hirashita, and Yasuhiro Wada, and Masahide Fukuda, and Osamu Matsunari, and Kazuhisa Okamoto, and Ryo Ogawa, and Kensuke Fukuda, and Yoko Kudo, and Yoshinari Kawahara, and Kazunari Murakami
April 2013, Gastrointestinal endoscopy,
Masaaki Kodama, and Tadayoshi Okimoto, and Kazuhiro Mizukami, and Yuka Hirashita, and Yasuhiro Wada, and Masahide Fukuda, and Osamu Matsunari, and Kazuhisa Okamoto, and Ryo Ogawa, and Kensuke Fukuda, and Yoko Kudo, and Yoshinari Kawahara, and Kazunari Murakami
July 1996, Journal of gastroenterology and hepatology,
Masaaki Kodama, and Tadayoshi Okimoto, and Kazuhiro Mizukami, and Yuka Hirashita, and Yasuhiro Wada, and Masahide Fukuda, and Osamu Matsunari, and Kazuhisa Okamoto, and Ryo Ogawa, and Kensuke Fukuda, and Yoko Kudo, and Yoshinari Kawahara, and Kazunari Murakami
June 2024, Scientific reports,
Masaaki Kodama, and Tadayoshi Okimoto, and Kazuhiro Mizukami, and Yuka Hirashita, and Yasuhiro Wada, and Masahide Fukuda, and Osamu Matsunari, and Kazuhisa Okamoto, and Ryo Ogawa, and Kensuke Fukuda, and Yoko Kudo, and Yoshinari Kawahara, and Kazunari Murakami
November 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Masaaki Kodama, and Tadayoshi Okimoto, and Kazuhiro Mizukami, and Yuka Hirashita, and Yasuhiro Wada, and Masahide Fukuda, and Osamu Matsunari, and Kazuhisa Okamoto, and Ryo Ogawa, and Kensuke Fukuda, and Yoko Kudo, and Yoshinari Kawahara, and Kazunari Murakami
February 2003, The journal of medical investigation : JMI,
Masaaki Kodama, and Tadayoshi Okimoto, and Kazuhiro Mizukami, and Yuka Hirashita, and Yasuhiro Wada, and Masahide Fukuda, and Osamu Matsunari, and Kazuhisa Okamoto, and Ryo Ogawa, and Kensuke Fukuda, and Yoko Kudo, and Yoshinari Kawahara, and Kazunari Murakami
January 2020, Frontiers in microbiology,
Masaaki Kodama, and Tadayoshi Okimoto, and Kazuhiro Mizukami, and Yuka Hirashita, and Yasuhiro Wada, and Masahide Fukuda, and Osamu Matsunari, and Kazuhisa Okamoto, and Ryo Ogawa, and Kensuke Fukuda, and Yoko Kudo, and Yoshinari Kawahara, and Kazunari Murakami
November 2013, International journal of cancer,
Masaaki Kodama, and Tadayoshi Okimoto, and Kazuhiro Mizukami, and Yuka Hirashita, and Yasuhiro Wada, and Masahide Fukuda, and Osamu Matsunari, and Kazuhisa Okamoto, and Ryo Ogawa, and Kensuke Fukuda, and Yoko Kudo, and Yoshinari Kawahara, and Kazunari Murakami
October 1997, Gastroenterology,
Masaaki Kodama, and Tadayoshi Okimoto, and Kazuhiro Mizukami, and Yuka Hirashita, and Yasuhiro Wada, and Masahide Fukuda, and Osamu Matsunari, and Kazuhisa Okamoto, and Ryo Ogawa, and Kensuke Fukuda, and Yoko Kudo, and Yoshinari Kawahara, and Kazunari Murakami
January 1996, The American journal of gastroenterology,
Masaaki Kodama, and Tadayoshi Okimoto, and Kazuhiro Mizukami, and Yuka Hirashita, and Yasuhiro Wada, and Masahide Fukuda, and Osamu Matsunari, and Kazuhisa Okamoto, and Ryo Ogawa, and Kensuke Fukuda, and Yoko Kudo, and Yoshinari Kawahara, and Kazunari Murakami
January 2014, Chinese medical journal,
Copied contents to your clipboard!